- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 59.08M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $56.53M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $55.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $187.46M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $281.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.47B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.49B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.01B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.59B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.61B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.99B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.06B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.11B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 60.49M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $26.82M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $111.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.39 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.39 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $66.76M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $49.41M |
| Net Income | Q1 2025 · Mar 31, 2024 | $26.23M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $66.87M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $316.38M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $572.89M |
| Revenue | Q1 2025 · Mar 31, 2024 | $889.27M |